Featured Content

By James Calder on August 28, 2025

US cuts to HIV aid could lead to 6 million infections and 4 million deaths by 2029. Explore the urgent global consequences.

By James Calder on August 27, 2025

The EU approved Gilead’s HIV prevention injection, Yeytuo. Learn how it works and why it could reshape global PrEP strategies.

By James Calder on August 27, 2025

Lenacapavir offers twice-yearly HIV prevention, but barriers like cost and insurance access raise global equity concerns.

By James Calder on August 25, 2025

Learn how to date with HIV in 2025 with confidence. Explore tips for disclosure, safety, and building healthy relationships.

By James Calder on August 25, 2025

Explore the latest HIV and AIDS research in 2025, from vaccines to long-acting treatments. Discover what science is tackling next.

By James Calder on August 25, 2025

HIV education in 2025 empowers communities. Learn what’s new, what works, and why knowledge is still our best tool.

By James Calder on August 25, 2025

Learn how the U=U campaign in 2025 is changing HIV awareness. Undetectable equals untransmittable—here’s why it’s a game-changer.

By James Calder on August 24, 2025

HIV and depression often go hand in hand. In 2025, mental health care is key to holistic HIV treatment. Learn more about symptoms and support.

By James Calder on August 24, 2025

AIDS funding cuts in 2025 are disrupting global care. Learn how these changes affect prevention, treatment, and vulnerable communities.

By James Calder on August 23, 2025

Explore the top HIV prevention drugs in 2025. Learn how PrEP, injectables, and new options are protecting more people than ever.

Recent Posts